|
Index of reports
> Cases with Hot Flush (26)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vivelle-DOT (Estradiol) where reactions include hot flush. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vivelle-DOT side effects in female
Reported by a physician from United States on 2012-08-26
Patient: female
Reactions: Poor Quality Sleep, Anxiety, Breast Pain, Application Site Reaction, Breast Swelling, Hot Flush, Dermatitis, Mastitis, Breast Mass, Rash, Breast Inflammation
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: 0.1 mg, bid
Start date: 2011-08-21
Vivelle-DOT
Dosage: 0.1 mg, bid
Indication: Hormone Replacement Therapy
Start date: 2009-01-01
Vivelle-DOT
Dosage: 0.1 mg, bid
Start date: 2011-08-27
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-21
Patient: female
Reactions: Application Site Reaction, Breast Pain, Mastitis, Breast Mass, Rash, Anxiety, Poor Quality Sleep, Breast Swelling, Hot Flush, Dermatitis, Breast Inflammation
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: 0.1 mg, bid
Start date: 2011-08-21
Vivelle-DOT
Dosage: 0.1 mg, bid
Start date: 2011-08-27
Vivelle-DOT
Dosage: 0.1 mg, bid
Indication: Hormone Replacement Therapy
Start date: 2009-01-01
Possible Vivelle-DOT side effects in female
Reported by a physician from United States on 2012-07-25
Patient: female, weighing 160.0 kg (352.0 pounds)
Reactions: Hot Flush, Mood Altered, Sleep Disorder, Drug Ineffective
Drug(s) suspected as cause:
Vivelle-DOT
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-12
Patient: female
Reactions: Weight Decreased, Night Sweats, Back Pain, Wrong Technique in Drug Usage Process, Drug Ineffective, Nausea, Cystocele, Hot Flush, Fatigue, Insomnia, Enterocele, Multiple Sclerosis, Menopausal Symptoms
Drug(s) suspected as cause:
Vivelle-DOT
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-02
Patient: female
Reactions: Weight Decreased, Night Sweats, Back Pain, Wrong Technique in Drug Usage Process, Drug Ineffective, Nausea, Cystocele, Hot Flush, Fatigue, Insomnia, Enterocele, Multiple Sclerosis, Menopausal Symptoms
Drug(s) suspected as cause:
Vivelle-DOT
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-02
Patient: female, weighing 160.0 kg (352.0 pounds)
Reactions: Hot Flush, Sleep Disorder, Drug Ineffective, Mood Altered
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Vivelle-DOT
Possible Vivelle-DOT side effects in
Reported by a pharmacist from United States on 2012-06-15
Patient:
Reactions: Hot Flush, Drug Ineffective, Mood Altered, Sleep Disorder
Drug(s) suspected as cause:
Vivelle-DOT
Possible Vivelle-DOT side effects in 46 year old female
Reported by a consumer/non-health professional from United States on 2012-05-14
Patient: 46 year old female, weighing 66.7 kg (146.7 pounds)
Reactions: Back Pain, Anxiety, Hot Flush, Palpitations, Panic Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Vivelle-DOT
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-26
Patient: female
Reactions: Hot Flush, Drug Ineffective, Insomnia, Depression
Drug(s) suspected as cause:
Vivelle-DOT
Possible Vivelle-DOT side effects in 59 year old female
Reported by a consumer/non-health professional from United States on 2012-03-26
Patient: 59 year old female
Reactions: Personality Change, Irritability, Hot Flush, Depression, Ulcer, Gastrooesophageal Reflux Disease
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: see image
Nexium
Dosage: 40 mg, bid
Indication: Gastrooesophageal Reflux Disease
Other drugs received by patient: Prometrium; Xanax; Hyzaar (Hydrochlorothazide, Losartan Potassium); Norvasc; Cymbalta
Possible Vivelle-DOT side effects in female
Reported by a individual with unspecified qualification from United States on 2012-01-31
Patient: female, weighing 61.7 kg (135.7 pounds)
Reactions: Pharyngeal Inflammation, Asthma, Dysphagia, Increased Upper Airway Secretion, Upper-Airway Cough Syndrome, Drug Hypersensitivity, General Physical Health Deterioration, Hot Flush, Dysphonia, Sleep Disorder, DRY Mouth, DRY Throat, Nasal Dryness, Cough, Infection
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: 0.025 mg, qw2
Start date: 2011-01-01
End date: 2011-01-01
Climara
Dosage: 0.0375 mg, qw2
End date: 2011-10-03
Azelastine HCL
Dosage: 0.15 %, one or two puffs as needed
Indication: Upper-Airway Cough Syndrome
Start date: 2011-01-01
Climara
Dosage: 0.0375 mg, once weekly
Indication: Hot Flush
Start date: 2011-01-01
Zyrtec
Dosage: spliting 10 mg tablet in to half
Medrol
Dosage: 4 mg, unk
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Premarin
Zyrtec
Dosage: 10 mg, daily
Indication: Antiallergic Therapy
Start date: 2011-01-01
Zithromax
Dosage: 250 mg, bid
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Other drugs received by patient: Losartan Potassium; Levoxyl; Vitamin D; Cyanocobalamin
Possible Vivelle-DOT side effects in female
Reported by a individual with unspecified qualification from United States on 2012-01-13
Patient: female
Reactions: Fatigue, Hot Flush, Wrong Technique in Drug Usage Process, Anaemia
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: 0.05 mg, twice weekly
Vivelle-DOT
Dosage: 0.05 mg, twice weekly
Other drugs received by patient: Hydrochlorothiazide; Hydrocodone Bitartrate; Lisinopril; Potassium Chloride; Wellbutrin XL
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-12
Patient: female, weighing 136.0 kg (299.2 pounds)
Reactions: Irritability, Anxiety, Product Quality Issue, Night Sweats, Hot Flush, Wrong Technique in Drug Usage Process, Drug Ineffective, Homicidal Ideation, Feeling Abnormal, Menopausal Symptoms
Drug(s) suspected as cause:
Vivelle-DOT
Indication: Hormone Replacement Therapy
Start date: 2000-01-01
End date: 2001-06-01
Vivelle-DOT
Dosage: 0.075 mg, qw2
Other drugs received by patient: Calcium; Vitamin D
Possible Vivelle-DOT side effects in female
Reported by a physician from United States on 2011-12-27
Patient: female, weighing 62.1 kg (136.7 pounds)
Reactions: Abdominal Pain, Wrong Technique in Drug Usage Process, Suprapubic Pain, Bladder Discomfort, Bladder Pain, Pelvic Pain, Micturition Urgency, Cystitis Interstitial, Bladder Irritation, Hot Flush, Heart Rate Decreased, Alopecia, Urethral Disorder, Stress Urinary Incontinence, Feeling Abnormal, Blood Pressure Diastolic Decreased
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: 0.05 mg, qw2
Elmiron
Dosage: 100 mg, bid
Administration route: Oral
Indication: Cystitis Interstitial
Start date: 2010-11-16
End date: 2010-11-19
Other drugs received by patient: Estrace; Nasacort; Avonex; Levothyroxine Sodium; Calcium Acetate; Vitamin D; Pramipexole Dihydrochloride; Ambien; Ventolin; Excedrin (Migraine); Multi-Vitamins; Acetaminophen; Magnesium; Fish OIL; Lovaza
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2011-12-14
Patient: female
Reactions: Poor Quality Sleep, Anxiety, Breast Pain, Hot Flush, Mastitis, Breast Mass, Rash, Breast Inflammation
Drug(s) suspected as cause:
Vivelle-DOT
Possible Vivelle-DOT side effects in female
Reported by a individual with unspecified qualification from United States on 2011-12-08
Patient: female
Reactions: Breast Pain, Inappropriate Schedule of Drug Administration, Nausea, Pain, Headache, Anxiety, Malaise, Hot Flush, Alopecia, Breast Tenderness, Thyroid Disorder, Muscle Spasms, Influenza Like Illness
Drug(s) suspected as cause:
Estrogens Conjugated
Vivelle-DOT
Dosage: 0.5 mg, unk
Vivelle-DOT
Dosage: 0.0375 mg, every 2 days
Other drugs received by patient: Synthroid; Synthroid; Bystolic; Ambient CPR
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2011-11-30
Patient: female, weighing 61.7 kg (135.7 pounds)
Reactions: Pharyngeal Inflammation, Asthma, Increased Upper Airway Secretion, Dysphagia, Upper-Airway Cough Syndrome, Hot Flush, DRY Mouth, Insomnia, DRY Throat, Nasal Inflammation, Nasal Dryness, Cough, Aphonia
Drug(s) suspected as cause:
Climara
Start date: 2011-01-01
End date: 2011-10-03
Zithromax
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Climara
Dosage: eleven plus years ago
Climara
Indication: Hysterectomy
Start date: 2011-01-01
End date: 2011-01-01
Climara
Start date: 2011-01-01
Medrol
Indication: Increased Upper Airway Secretion
Start date: 2011-01-01
End date: 2011-01-01
Azelastine HCL
Dosage: one or two puffs as needed
Indication: Upper-Airway Cough Syndrome
Start date: 2011-01-01
Zyrtec
Dosage: splitting the tablets in half
Administration route: Oral
Indication: Antiallergic Therapy
Start date: 2011-01-01
Zithromax
Start date: 2011-01-01
End date: 2011-01-01
Medrol
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Zyrtec
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Vivelle-DOT
Indication: Hysterectomy
Start date: 2011-01-01
End date: 2011-01-01
Zithromax
Dosage: as per the course
Indication: Increased Upper Airway Secretion
Start date: 2011-01-01
End date: 2011-01-01
Zithromax
Dosage: as per the course
Start date: 2011-01-01
End date: 2011-01-01
Other drugs received by patient: Cozaar
Possible Vivelle-DOT side effects in female
Reported by a individual with unspecified qualification from United States on 2011-11-28
Patient: female, weighing 61.7 kg (135.7 pounds)
Reactions: Pharyngeal Inflammation, Asthma, Increased Upper Airway Secretion, Dysphagia, Drug Hypersensitivity, Upper-Airway Cough Syndrome, General Physical Health Deterioration, Hot Flush, Sleep Disorder, Dysphonia, DRY Throat, DRY Mouth, Nasal Dryness, Cough, Infection
Drug(s) suspected as cause:
Climara
Dosage: 0.0375 mg, qw2
End date: 2011-10-03
Premarin
Dosage: unk ukn, unk
Medrol
Dosage: 4 mg, unk
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Azelastine HCL
Dosage: 0.15 %, one or two puffs as needed
Indication: Upper-Airway Cough Syndrome
Start date: 2011-01-01
Zithromax
Dosage: 250 mg, bid
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Vivelle-DOT
Dosage: 0.025 mg, qw2
Start date: 2011-01-01
End date: 2011-01-01
Climara
Dosage: 0.0375 mg, once weekly
Indication: Hot Flush
Start date: 2011-01-01
Zyrtec
Dosage: 10 mg, daily
Indication: Antiallergic Therapy
Start date: 2011-01-01
Zyrtec
Dosage: spliting 10 mg tablet in to half
Other drugs received by patient: Losartan Potassium; Vitamin D; Levoxyl; Cyanocobalamin
Possible Vivelle-DOT side effects in female
Reported by a individual with unspecified qualification from United States on 2011-11-21
Patient: female, weighing 61.7 kg (135.7 pounds)
Reactions: Pharyngeal Inflammation, Asthma, Dysphagia, Increased Upper Airway Secretion, Upper-Airway Cough Syndrome, Drug Hypersensitivity, General Physical Health Deterioration, Hot Flush, Sleep Disorder, Dysphonia, DRY Throat, DRY Mouth, Nasal Dryness, Cough, Infection
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: 0.0275 mg, qw2
Start date: 2011-01-01
End date: 2011-01-01
Climara
Dosage: 0.0375 mg, once weekly
Indication: Hot Flush
Start date: 2011-01-01
Zyrtec
Dosage: 10 mg, daily
Indication: Antiallergic Therapy
Start date: 2011-01-01
Premarin
Dosage: unk ukn, unk
Zithromax
Dosage: 250 mg, bid
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Azelastine HCL
Dosage: 0.15 %, one or two puffs as needed
Indication: Upper-Airway Cough Syndrome
Start date: 2011-01-01
Climara
Dosage: 0.0375 mg, qw2
End date: 2011-10-03
Zyrtec
Dosage: spliting 10 mg tablet in to half
Medrol
Dosage: 4 mg, unk
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Other drugs received by patient: Levoxyl; Vitamin D; Cyanocobalamin; Losartan
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2011-11-18
Patient: female, weighing 61.7 kg (135.7 pounds)
Reactions: Asthma, Pharyngeal Inflammation, Increased Upper Airway Secretion, Dysphagia, Upper-Airway Cough Syndrome, Hot Flush, Insomnia, DRY Throat, DRY Mouth, Nasal Inflammation, Nasal Dryness, Cough, Aphonia
Drug(s) suspected as cause:
Vivelle-DOT
Indication: Hysterectomy
Start date: 2011-01-01
End date: 2011-01-01
Zyrtec
Dosage: splitting the tablets in half
Administration route: Oral
Indication: Antiallergic Therapy
Start date: 2011-01-01
Climara
Dosage: eleven plus years ago
Zithromax
Dosage: as per the course
Start date: 2011-01-01
End date: 2011-01-01
Climara
Indication: Hysterectomy
Start date: 2011-01-01
End date: 2011-01-01
Climara
Start date: 2011-01-01
End date: 2011-10-03
Zithromax
Start date: 2011-01-01
End date: 2011-01-01
Zithromax
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Zithromax
Dosage: as per the course
Indication: Increased Upper Airway Secretion
Start date: 2011-01-01
End date: 2011-01-01
Medrol
Indication: Increased Upper Airway Secretion
Start date: 2011-01-01
End date: 2011-01-01
Medrol
Indication: Cough
Start date: 2011-01-01
End date: 2011-01-01
Azelastine HCL
Dosage: one or two puffs as needed
Indication: Upper-Airway Cough Syndrome
Start date: 2011-01-01
Zyrtec
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Climara
Start date: 2011-01-01
Other drugs received by patient: Cozaar
Possible Vivelle-DOT side effects in 60 year old female
Reported by a consumer/non-health professional from United States on 2011-11-18
Patient: 60 year old female, weighing 61.7 kg (135.7 pounds)
Reactions: Aphagia, Asthma, Nightmare, Increased Upper Airway Secretion, Upper-Airway Cough Syndrome, Upper Respiratory Tract Inflammation, Hot Flush, Insomnia, DRY Throat, DRY Mouth, Nasal Dryness, Cough, Aphonia
Drug(s) suspected as cause:
Climara
Dosage: 0375 mg, unk
Indication: Hysterectomy
Start date: 2011-01-01
End date: 2011-10-03
Climara
Dosage: 0.375 mg, unk
Indication: Autonomic Nervous System Imbalance
Start date: 2000-01-01
Vivelle-DOT
Dosage: 0.275 mg, q2wk
Indication: Hysterectomy
Start date: 2011-01-01
Other drugs received by patient: Losartan
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-31
Patient: female
Reactions: Breast Pain, Migraine, Hot Flush, Alopecia, DRY Mouth, Asthenia, Vocal Cord Cyst
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: 0.1 mg, qw2
Vivelle-DOT
Dosage: 0.075 mg, qw2
Vivelle-DOT
Dosage: 0.075 mg, qw2
Fluoxetine HCL
Dosage: 20 mg, qd
Administration route: Oral
Indication: Depression
Other drugs received by patient: Cyclobenzaprine Hydrochloride; Cyclobenzaprine Hydrochloride; Cyclobenzaprine Hydrochloride
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-31
Patient: female
Reactions: Breast Pain, Migraine, Hot Flush, Alopecia, DRY Mouth, Asthenia, Vocal Cord Cyst
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: 0.075 mg, qw2
Fluoxetine HCL
Dosage: 20 mg, qd
Administration route: Oral
Indication: Depression
Vivelle-DOT
Dosage: 0.1 mg, qw2
Vivelle-DOT
Dosage: 0.075 mg, qw2
Other drugs received by patient: Cyclobenzaprine Hydrochloride; Cyclobenzaprine Hydrochloride; Cyclobenzaprine Hydrochloride
Possible Vivelle-DOT side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-24
Patient: female, weighing 136.0 kg (299.2 pounds)
Reactions: Irritability, Anxiety, Night Sweats, Hot Flush, Wrong Technique in Drug Usage Process, Drug Ineffective, Feeling Abnormal, Menopausal Symptoms
Drug(s) suspected as cause:
Vivelle-DOT
Indication: Hormone Replacement Therapy
Start date: 2000-01-01
End date: 2001-06-01
Vivelle-DOT
Dosage: 0.075 mg, qw2
Other drugs received by patient: Vitamin D; Calcium Carbonate
Possible Vivelle-DOT side effects in female
Reported by a individual with unspecified qualification from United States on 2011-10-14
Patient: female
Reactions: Night Sweats, Hot Flush, Nausea, Headache, Thyroid Neoplasm, Feeling Abnormal, Gastroenteritis Viral
Drug(s) suspected as cause:
Vivelle-DOT
Dosage: 0.05 mg, unk
Start date: 2011-09-19
Vivelle-DOT
Dosage: unk
Vivelle-DOT
Dosage: 0.037 mg, unk
Start date: 2011-08-01
Vivelle-DOT
Dosage: 0.037 mg, unk
Other drugs received by patient: Estradiol; Aspirin; Troporol; Lovaza; Avalide
Possible Vivelle-DOT side effects in female
Reported by a individual with unspecified qualification from United States on 2011-10-04
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Product Quality Issue, Night Sweats, Drug Ineffective, Irritability, Anxiety, Hot Flush, Blood Oestrogen Decreased, Feeling Abnormal, Crying, Menopausal Symptoms
Drug(s) suspected as cause:
Vivelle-DOT
|
